BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 18981167)

  • 1. The carnitine transporter SLC22A5 is not a general drug transporter, but it efficiently translocates mildronate.
    Grigat S; Fork C; Bach M; Golz S; Geerts A; Schömig E; Gründemann D
    Drug Metab Dispos; 2009 Feb; 37(2):330-7. PubMed ID: 18981167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5).
    Grube M; Meyer zu Schwabedissen HE; Präger D; Haney J; Möritz KU; Meissner K; Rosskopf D; Eckel L; Böhm M; Jedlitschky G; Kroemer HK
    Circulation; 2006 Feb; 113(8):1114-22. PubMed ID: 16490820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of mildronate with the mitochondrial carnitine/acylcarnitine transport protein.
    Oppedisano F; Fanello D; Calvani M; Indiveri C
    J Biochem Mol Toxicol; 2008 Feb; 22(1):8-14. PubMed ID: 18273902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
    Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
    J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse.
    Kato Y; Sugiura M; Sugiura T; Wakayama T; Kubo Y; Kobayashi D; Sai Y; Tamai I; Iseki S; Tsuji A
    Mol Pharmacol; 2006 Sep; 70(3):829-37. PubMed ID: 16754783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carnitine/organic cation transporter OCTN2-mediated transport of carnitine in primary-cultured epididymal epithelial cells.
    Kobayashi D; Irokawa M; Maeda T; Tsuji A; Tamai I
    Reproduction; 2005 Dec; 130(6):931-7. PubMed ID: 16322553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier.
    Friedrich A; Prasad PD; Freyer D; Ganapathy V; Brust P
    Brain Res; 2003 Apr; 968(1):69-79. PubMed ID: 12644265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate discrimination by ergothioneine transporter SLC22A4 and carnitine transporter SLC22A5: gain-of-function by interchange of selected amino acids.
    Bacher P; Giersiefer S; Bach M; Fork C; Schömig E; Gründemann D
    Biochim Biophys Acta; 2009 Dec; 1788(12):2594-602. PubMed ID: 19814996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein.
    Ohashi R; Tamai I; Inano A; Katsura M; Sai Y; Nezu J; Tsuji A
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1286-94. PubMed ID: 12183691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle contraction increases carnitine uptake via translocation of OCTN2.
    Furuichi Y; Sugiura T; Kato Y; Takakura H; Hanai Y; Hashimoto T; Masuda K
    Biochem Biophys Res Commun; 2012 Feb; 418(4):774-9. PubMed ID: 22310714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnitine/organic cation transporter OCTN2 (Slc22a5) is responsible for renal secretion of cephaloridine in mice.
    Kano T; Kato Y; Ito K; Ogihara T; Kubo Y; Tsuji A
    Drug Metab Dispos; 2009 May; 37(5):1009-16. PubMed ID: 19220985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological rescue of carnitine transport in primary carnitine deficiency.
    Amat di San Filippo C; Pasquali M; Longo N
    Hum Mutat; 2006 Jun; 27(6):513-23. PubMed ID: 16652335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.
    Wu X; Huang W; Prasad PD; Seth P; Rajan DP; Leibach FH; Chen J; Conway SJ; Ganapathy V
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1482-92. PubMed ID: 10454528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21).
    Tamai I
    Biopharm Drug Dispos; 2013 Jan; 34(1):29-44. PubMed ID: 22952014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.
    Tamai I; Ohashi R; Nezu J; Yabuuchi H; Oku A; Shimane M; Sai Y; Tsuji A
    J Biol Chem; 1998 Aug; 273(32):20378-82. PubMed ID: 9685390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-Carnitine transport in mouse renal and intestinal brush-border and basolateral membrane vesicles.
    Lahjouji K; Malo C; Mitchell GA; Qureshi IA
    Biochim Biophys Acta; 2002 Jan; 1558(1):82-93. PubMed ID: 11750267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5).
    Urban TJ; Gallagher RC; Brown C; Castro RA; Lagpacan LL; Brett CM; Taylor TR; Carlson EJ; Ferrin TE; Burchard EG; Packman S; Giacomini KM
    Mol Pharmacol; 2006 Nov; 70(5):1602-11. PubMed ID: 16931768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart.
    Iwata D; Kato Y; Wakayama T; Sai Y; Kubo Y; Iseki S; Tsuji A
    Drug Metab Pharmacokinet; 2008; 23(3):207-15. PubMed ID: 18574325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The plasma carnitine concentration regulates renal OCTN2 expression and carnitine transport in rats.
    Schürch R; Todesco L; Novakova K; Mevissen M; Stieger B; Krähenbühl S
    Eur J Pharmacol; 2010 Jun; 635(1-3):171-6. PubMed ID: 20303936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species specificity profiling of rat and human organic cation/carnitine transporter Slc22a5/SLC22A5 (Octn2/OCTN2).
    Szabó K; Nagy Z; Juhász V; Zolnerciks JK; Csorba A; Tímár Z; Molnár É; Pádár P; Johnson W; Beéry E; Krajcsi P
    Drug Metab Pharmacokinet; 2017 Jun; 32(3):165-171. PubMed ID: 28365301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.